Amferia develops innovative medical devices to solve the antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to bring to the market a highly efficient anti-infective wound patch for humans that can prevent bacterial skin infections including antibiotic resistant infections. Amferia’s proprietary technology is a result of several years of research from Chalmers University of Technology.